Team

bernat-olle-ph-d

Bernat Olle, Ph.D.

Chief Executive Officer

bernat-olle-ph-d

Bernat Olle, Ph.D.

Chief Executive Officer

Dr. Olle is a co-founder and Chief Executive Officer of Vedanta Biosciences. He has been a member of the founding teams of several companies of the PureTech portfolio and served as a member of the Board of Directors of Vedanta Biosciences and Follica Biosciences.

In 2013 Dr. Olle was named "Innovator of the Year" in MIT Technology Review Spain's "Innovators under 35" awards. He also received the 2019 Barry M. Portnoy Immigrant Entrepreneur Award from The Immigrant Learning Center.

He completed his doctoral work at the Chemical Engineering Department at MIT, where he developed a novel method for large-scale bacterial culture. During his graduate work, Dr. Olle was awarded the "la Caixa" fellowship. Dr. Olle received his B.S. in Chemical Engineering from Universitat Rovira i Virgili, in Catalonia, his M.S. and PhD. in Chemical Engineering Practice from MIT, and his M.B.A. from the MIT Sloan School of Management. He has published his work in journals including Nature and Nature Biotechnology.

Ending the War on Microbes | Bernat Olle | TEDxCambridge

dan-couto

Dan Couto

Chief Operating Officer

dan-couto

Dan Couto

Chief Operating Officer

Mr. Couto has 25 years of experience in biotechnology, biologics drug development and cGMP manufacturing, including at Merck Sharp Dohme Biologics UK (formerly Avecia Biologics) where he served as Vice President of Commercial Manufacturing Operations and was responsible for late stage and commercial manufacturing operations. In addition, Mr. Couto has held senior positions with several biotech companies including Nuvelo, Genzyme Transgenics and Advanced Biosystems and, most recently, was Senior Vice President of Manufacturing and Facilities Operations at ContraFect Corporation where he was responsible for chemistry & manufacturing controls, supply chain, quality assurance and facilities.

Mr. Couto holds multiple U.S. patents. He received his B.S. in Chemical Engineering from Rensselaer Polytechnic Institute.

jeffrey-silber-m-d

Jeffrey Silber, M.D.

Chief Medical Officer

jeffrey-silber-m-d

Jeffrey Silber, M.D.

Chief Medical Officer

Dr. Silber joined Vedanta as its first Chief Medical Officer in September 2020.  He has over 30 years of academic and pharmaceutical industry experience, having most recently served as Senior Vice President in Clinical Development and Head of Development Sciences at EMD Serono/Merck KGaA.  While there, he oversaw Global Program Leadership, Global Patient Safety, Fertility/Endocrine Clinical Research, and more recently Biostatistics & Epidemiology and Translational Medicine.  

Before joining EMD Serono, Dr. Silber was Vice President and Head of Strategic Portfolio Development at AbbVie.  Prior to that, he served in roles of increasing responsibility in Vaccines, Anti-infectives, and Neuroscience over a 16-year career at Merck & Co., ultimately rising to the position of Vice President and Therapeutic Area Head, Vaccine Clinical Research. He previously served as an Assistant Professor of Medicine at UMDNJ/Robert Wood Johnson School of Medicine in Camden, NJ. 

Dr. Silber received his B.A. from Harvard and his M.D. from the Albert Einstein College of Medicine.  He completed training in Internal Medicine at NYU Medical Center/Bellevue Hospital and in Infectious Diseases at the Hospital of the University of Pennsylvania. 

mark-mullikin

Mark Mullikin

Chief Financial Officer

mark-mullikin

Mark Mullikin

Chief Financial Officer

Mr. Mullikin was appointed Chief Financial Officer of Vedanta in February 2021. He brings with him 25 years of experience raising and deploying capital for life sciences companies, most recently at Editas Medicine, where he served as Vice President, Finance and Investor Relations and was involved in raising $700 million of equity capital.

Prior to this role, Mr. Mullikin worked for Novartis, focusing on financial and strategic planning as well as health economics and pricing. Before Novartis, he was a healthcare equity analyst at Adage Capital Management and Piper Sandler and began his career in the finance and strategy practice at Deloitte Consulting.

Mr. Mullikin earned his M.B.A. in finance from the MIT Sloan School of Management and his B.A. in economics from the University of Chicago.
debra-winslow

Debra Winslow

VP, Program Management & Operations Planning

debra-winslow

Debra Winslow

VP, Program Management & Operations Planning

Deb Winslow has joined Vedanta after working in the biotech industry for over 25 years in various roles from early product development through commercialization.  She received a BS in biochemistry from UNH, an MBA from Bentley University, is a Regulatory Affairs Certified (RAC) professional and a Project Management Professional (PMP).  Her roles is to set up program management and operational planning systems to ensure successful program execution across the company.

jack-kyte

Jack Kyte

VP, Human Resources

lorraine-hughes

Lorraine Hughes

VP, Clinical Operations

lorraine-hughes

Lorraine Hughes

VP, Clinical Operations

Lorraine Hughes joined Vedanta with over 30 years of pharmaceutical/biotech industry experience providing strategic and operational leadership in multiple therapeutic areas, including but not limited to, leading the efforts of clinical operation teams conducting clinical trials for registration and approval of new drug applications. She received her BS in biology from Towson University and MS in Business from Johns Hopkins University.

nancy-wilker-ph-d-j-d

Nancy Wilker, Ph.D., J.D.

VP, Head of Legal Affairs and IP

nancy-wilker-ph-d-j-d

Nancy Wilker, Ph.D., J.D.

VP, Head of Legal Affairs and IP

Dr. Nancy Wilker is VP, Head of Legal Affairs and IP, and Corporate Secretary of Vedanta Biosciences. She has more than 20 years of experience in the life science industry. Prior to joining Vedanta, she served as vice president, lead IP counsel, for Fog Pharmaceuticals, Inc., where she oversaw that company’s IP estate and contracts. Prior to Fog, Dr. Wilker held IP counsel roles at Biogen, Seqirus, Cell Signaling Technology, and PerkinElmer. Earlier in her career, Dr. Wilker was a partner in the life sciences patent practice group at Sunstein LLP, and an associate at WilmerHale.  

Dr. Wilker holds a B.S. in biochemistry and biology from Colorado State University; a Ph.D. in immunology from Harvard University; and a J.D. from Suffolk University Law School.

aaron-bushold

Aaron Bushold

QC Manager

adam-curet

Adam Curet

Laboratory Manager

adam-tomich

Adam Tomich

Principal Research Associate, Process Development

adrian-douglas

Adrian Douglas

Maintenance Technician

alex-buckley

Alex Buckley

Manager, Supply Chain

alexandrea-kreuser

Alexandrea Kreuser

Clinical Supply Chain Associate

alicia-szretter

Alicia Szretter

Manager, Manufacturing

amanda-prince

Amanda Prince

Sr. Scientist, Immunology

cintia-felix

Cintia Felix

Scientist II

colin-heberling

Colin Heberling

Principal Research Associate

dan-clarici

Dan Clarici

Process Engineer II

dave-crane

Dave Crane

Sr. Manager, Quality Assurance

dave-pais

Dave Pais

Sr. Director Program Management

diana-wiesnoski

Diana Wiesnoski

Scientist I, Molecular Biology

henok-kaptimer

Henok Kaptimer

Supply Chain Associate

jared-hendrickson

Jared Hendrickson

Research Associate, Bioinformatics

jason-norman-ph-d

Jason Norman, Ph.D.

Director, Systems Biology

jen-nguyen

Jen Nguyen

Senior QC Specialist

jil-ulrich

Jil Ulrich

Director, CMC Operations

johannes-almodovar

Johannes Almodovar

Document Control & Record Management Specialist

jordan-pothier

Jordan Pothier

Senior Coordinator, Clinical & Translational Medicine

kathryn-dudley

Kathryn Dudley

EA & Executive Administrator

kelsey-brown

Kelsey Brown

Program Manager

kris-ireland

Kris Ireland

Sr. Director, Manufacturing

lou-cornacchione

Lou Cornacchione

Scientist II

maggie-mcguigan

Maggie McGuigan

Sr. Director, Finance

maria-kim

Maria Kim

Clinical Trial Manager

melissa-dsouza

Melissa Dsouza

Scientist II, Analytical Development

mitra-shirolkar

Mitra Shirolkar

QA Specialist

mollie-murnane

Mollie Murnane

Sr. Research Associate, Microbiology - Platform

pip-reeder

Pip Reeder

Director, Process Development

rajita-menon

Rajita Menon

Senior Scientist, Modeling & Statistics

rayssa-delorey

Rayssa Delorey

Technical Operations Engineer

robert-dorazio

Robert D’Orazio

Lead Manufacturing Associate

rohan-chengappa

Rohan Chengappa

Process Development Engineer

rose-szabady-ph-d

Rose Szabady, Ph.D.

Director, Immunology

rowan-pereira

Rowan Pereira

Receptionist/Office Coordinator

ryan-busha

Ryan Busha

Sr. Sample Management Manager

sabrina-pearson

Sabrina Pearson

Senior Research Associate – Microbiology

sean-mcgrath

Sean McGrath

Sr. Manufacturing Associate

shana-westover

Shana Westover

Clinical Trial Manager

shanfu-xie

Shanfu Xie

Sr. Research Associate, Molecular Bio & Sequencing

shilpa-reddy

Shilpa Reddy

Scientist I

shrishti-pitti

Shrishti Pitti

Senior Regulatory Specialist

silvia-caballero-ph-d

Silvia Caballero, Ph.D.

Director, Infectious Diseases

steve-derby

Steve Derby

Lead Manufacturing Associate

suzanne-bedard-shurtleff

Suzanne Bedard-Shurtleff

Suzanne Bedard-Shurtleff

taylor-feehley

Taylor Feehley

Sr. Director, Corporate Strategy & Development

thomas-madore

Thomas Madore

Accounting Manager

thomas-o039-brien

Thomas O'Brien

Sr. Director, Quality

tyler-hale

Tyler Hale

Sr. QC Specialist